REPROCELL is a leading brand in the field of translational research, offering a wide range of services and products to support scientific advancements. With laboratories and scientists located across the USA, UK, and Japan, REPROCELL has the expertise and resources to effectively translate discoveries into therapies. Their extensive portfolio includes a comprehensive product catalog for stem cell research and 3D bioengineered tissues, a biorepository of ethically-sourced human tissues, and clinical networks in the US and Europe for contract research services.

REPROCELL also supplies induced pluripotent stem cells (iPSCs) for both research and clinical applications. In addition to their existing services, REPROCELL is actively involved in developing regenerative medicine therapies for neurodegenerative diseases and conducting clinical trials in Japan. They also offer diagnostic and clinical research services across multiple labs worldwide.

With their broad range of capabilities, REPROCELL is a fully integrated partner for the life sciences industry, providing support in drug discovery and regenerative medicine. Their dedicated team of over 100 scientists ensures that customers receive high-quality products and services tailored to their specific needs. Founded in 2003 by renowned Japanese university researchers, REPROCELL has a rich history in stem cell research and has since expanded through strategic acquisitions.

This expansion has allowed them to offer a comprehensive workflow, encompassing human tissue acquisition, RNA reprogramming, 3D technologies, and drug discovery. Trust, innovation, value, customer focus, and quality are the core values that underpin all of REPROCELL's activities, allowing them to deliver exceptional tools and services that accelerate and de-risk research workflows and medical applications. With their advanced technologies and commitment to excellence, REPROCELL is a trusted partner in the scientific community